Case series of creatine deficiency syndrome due to guanidinoacetate methyltransferase deficiency
Guanidinoacetate methyltransferase (GAMT) deficiency is the second most common defect in the creatine metabolism pathway resulting in cerebral creatine deficiency syndrome (CCDS).
Vinu Narayan +3 more
doaj +1 more source
Urine creatine metabolite panel as a screening test in neurodevelopmental disorders
Background Cerebral creatine deficiency disorders (CCDD) are inherited metabolic disorders of creatine synthesis and transport. Urine creatine metabolite panel is helpful to identify these disorders.
Shalini Bahl +4 more
doaj +1 more source
Reversal of refractory epilepsy in an adult with GAMT deficiency: A case report and comparative literature review [PDF]
Abstract Objective Guanidinoacetate methyltransferase (GAMT) deficiency is a rare autosomal recessive creatine biosynthesis disorder. Reports specifically focusing on adult patients remain scarce. Methods We report a 52‐year‐old female (the oldest documented case of GAMT deficiency to date) presenting with severe intellectual disability, refractory ...
Sung W, Chen H, Hsu C, Tsai M.
europepmc +2 more sources
Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention
Increasing evidence suggests that the autism spectrum disorder (ASD) may be associated with inborn errors of metabolism, such as disorders of amino acid metabolism and transport [phenylketonuria, homocystinuria, S-adenosylhomocysteine hydrolase ...
Tamara Žigman +3 more
doaj +1 more source
Among cerebral creatine deficiency syndromes, guanidinoacetate methyltransferase (GAMT) deficiency can present the most severe symptoms, and is characterized by neurocognitive dysfunction due to creatine deficiency and accumulation of guanidinoacetate in
Layane Hanna-El-Daher +4 more
doaj +1 more source
Value of magnetic resonance spectroscopy for diagnosis of creatine deficiency syndrome
WOS:000633691200001Creatine deficiency syndromes are congenital metabolic diseases characterized by decreased cerebral creatine levels as a result of disorders in creatine synthesis and transport.
Hattapoğlu, Salih +2 more
core +1 more source
Novel translational phenotypes and biomarkers for creatine transporter deficiency [PDF]
Creatine transporter deficiency is a metabolic disorder characterized by intellectual disability, autistic-like behaviour and epilepsy. There is currently no cure for creatine transporter deficiency, and reliable biomarkers of translational value for ...
Sagona, Giulia +23 more
core +1 more source
Creatine protects against excitoxicity in an in vitro model of neurodegeneration. [PDF]
Creatine has been shown to be neuroprotective in aging, neurodegenerative conditions and brain injury. As a common molecular background, oxidative stress and disturbed cellular energy homeostasis are key aspects in these conditions. Moreover, in a recent
Geiger Johanna +17 more
core +1 more source
Creatine transporter deficiency impairs stress adaptation and brain energetics homeostasis
The creatine transporter (CrT) maintains brain creatine (Cr) levels, but the effects of its deficiency on energetics adaptation under stress remain unclear.
Hong-Ru Chen +13 more
doaj +1 more source
Cerebral Creatine Deficiency Syndromes [PDF]
Introduction: Creatine deficiency syndromes are a recently described group of diseases characterized by inborn errors of creatine metabolism. Clinical features include a spectrum of neurodevelopment disorders of diverse severity.
Diogo, L +4 more
core +1 more source

